A Phase 4 interventional study of MEDICLORE in Adhesion and Thyroidectomy, sponsored by Seoul National University Hospital. Completed at 1 site in Korea, Republic of. Open to participants aged 20 Years to 70 Years. Per ClinicalTrials.gov, last updated 2021-03-17.
Sponsored by Seoul National University Hospital · Phase 4, Interventional, and Prevention
One of most important complication of thyroid surgery is adhesion. There are many anti-adhesive materials, but none of them showed significant outcomes. The investigators planned double blind prospective study of "Thermo-sensitive Adhesion Barrier (MEDICLORE)" to reveal anti-adhesive effect of MEDICLORE. The investigators will recruit total 90 patients (control group 45, experimental group 45) and compare postoperative outcomes about adhesion.
121 studies on the registry are indexed under Tissue Adhesions; 15 are open to participants now.
This study's enrollment of 90 is above the median of 61 across 84 interventional studies indexed under Tissue Adhesions.
Browse Tissue Adhesions studies →Seoul National University Hospital is the lead sponsor of 1,900 studies on the registry; 274 are open to participants now.
Of its 12 completed or terminated interventional studies of FDA-regulated products, 2 (17%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Cancer that has spread from where it began to other parts of the body. “Metastatic” cancer is cancer that has spread this way.
Metastases
Cancer that has spread from where it began to other parts of the body. “Metastatic” cancer is cancer that has spread this way.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
use mediclore at the end of surgery
Combination Product: MEDICLORE
use no antiadhesive product at the end of surgery
use MEDICLORE at the end of surgery as antiadhesive product
Changes of postoperative adhesion will checked using answer of questionnaire that participants and physicians replied.
Time frame: Participants will be followed from the operation to postoperative 2weeks, 3months, 6months
Plan to share: No
No publications or documents are linked to this record.
Ran from Jul 2017 to primary completion in Dec 2020, 41 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Mar 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Seoul National University Hospital →